COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,551 Articles (22,881 medRxiv, 8,670 bioRxiv)

Most recent first Previous |  Page 2019: Articles 20181-20190  | Next

Through The Back Door: Expiratory Accumulation of SARS-Cov-2 in the Olfactory Mucosa as Mechanism for CNS Penetration
Quadrio, M., Pipolo, C., Bulfamante, A. M., Schillaci, A., Banchetti, J., Castellani, L., Saibene, A. M., Felisati, G.
10.1101/2020.12.09.20242396 — Posted: 2020-12-11
Artificial intelligence-enabled analysis of UK and US public attitudes on Facebook and Twitter towards COVID-19 vaccinations
Hussain, A., Tahir, A., Hussain, Z., Sheikh, Z., Gogate, M., Dashtipour, K., Ali, A., Sheikh, A.
10.1101/2020.12.08.20246231 — Posted: 2020-12-11
Characterizing the Dynamic of COVID-19 with a New Epidemic Model: Susceptible-Exposed-Symptomatic-Asymptomatic-Active-Removed
Yi, G. Y., Hu, P., He, W.
10.1101/2020.12.08.20246264 — Posted: 2020-12-11
Contacts and behaviours of university students during the COVID-19 pandemic at the start of the 2020/21 academic year
Nixon, E. J., Trickey, A., Christensen, H., Finn, A., Thomas, A., Relton, C., Montgomery, C., Hemani, G., Metz, J., Walker, J., Turner, K., Kwiatkowska, R., Sauchelli, S., Danon, L., Brooks-Pollock, E.
10.1101/2020.12.09.20246421 — Posted: 2020-12-11
Analysis of the specificity of the SD Biosensor Standard Q Ag-Test based on Slovak mass testing data
Hledik, M., Polechova, J., Beiglboeck, M., Herdina, A. N., Strassl, R., Posch, M.
10.1101/2020.12.08.20246090 — Posted: 2020-12-11 Discussion: Onsite
Characterizing superspreading of SARS-CoV-2: from mechanism to measurement
Susswein, Z., Bansal, S.
10.1101/2020.12.08.20246082 — Posted: 2020-12-11 Discussion: Onsite
Management of the COVID-19 health crisis: A survey in Swiss hospital pharmacies
Schumacher, L., Dhif, Y., Bonnabry, P., Widmer, N.
10.1101/2020.12.08.20237339 — Posted: 2020-12-11
Effect of clustering and correlation of belief systems on infectious disease outbreaks
Kadelka, C., McCombs, A.
10.1101/2020.12.08.20246298 — Posted: 2020-12-11
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., Pascal, K., Maurus, D., Brachtendorf, S., Loerks, V. L., Sikorski, J., Koch, P., Hilker, R., Becker, D., Eller, A.-K., Gruetzner, J., Tonigold, M., Boesler, C., Rosenbaum, C., Heesen, L., Kuehnle, M.-C., Poran, A., Dong, J. Z., Luxemburger, U., Kemmer-Brueck, A., Langer, D., Bexon, M., Bolte, S., Palanche, T., Schultz, A., Baumann, S., Mahiny, A. J., Boros, G., Reinholz, J., Szabo, G. T., Kariko, K., Shi, P.-Y., Fontes-Garfias, C., Perez, J. L., Cutler, M., Cooper, D., Kyratsous, C. A., Dormitzer, P. R., Jansen, K. U., Tuereci, O.
10.1101/2020.12.09.20245175 — Posted: 2020-12-11 Discussion: Onsite | Offsite
Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19
Yokoyama, A. P. H., Wendel, S., Bonet-Bub, C., Fachini, R. M., Dametto, A. P. F., Blumm, F., Dutra, V. F., Candelaria, G., Sakashita, A. M., Machado, R. R. G., Fontao-Wendel, R., Hamerschlak, N., Achkar, R., Assuncao, M., Scuracchio, P., Nudelman, V., Pastore, L., Pinho, J. R. R., Dal Ben, M., Kalil Filho, R., Marra, A. R., Amano, M. T., Kallas, E., Helito, A. S., Carvalho, C. R. R., Araujo, D. B., Durigon, E. L., Camargo, A. A., Rizzo, L. V., Reis, L. F. L., Kutner, J. M.
10.1101/2020.12.08.20246173 — Posted: 2020-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).